ReviewFrontiers in public health2026
Governing antimicrobial resistance through One Health: a comparative analysis of public health governance in China and the United Kingdom.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) has emerged as one of the most pressing threats to global health and a major challenge for contemporary public health governance. As the drivers of AMR span human, animal, and environmental systems, the One Health framework has become central to the design of effective containment strategies. This study compares AMR governance in China and the United Kingdom (UK), focusing on institutional organization, regulatory frameworks, surveillance systems, and mechanisms for cross-sectoral coordination. The analysis highlights two contrasting governance models within the broader One Health paradigm. China relies on strong state-led coordination and hierarchical administrative mobilization, whereas the UK emphasizes specialized institutional collaboration supported by integrated surveillance infrastructures. Despite these structural differences, both countries continue to face major challenges in environmental surveillance, intersectoral data integration, and long-term coordination across sectors. Future progress in AMR control will depend not only on strengthening multisectoral governance capacity, but also on improving the integration of environmental dimensions into existing surveillance and response systems. The comparative experiences of China and the UK offer broader insights into the development of adaptive and globally coordinated One Health strategies for AMR governance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.